Back to dashboard
Low impact

Clesrovimab-cfor (Enflonsia) (CPB 1088, reviewed 09-2025-10)

Aetna·Medical Policy
Effective date
Not stated
We identified it
Aug 13, 2026
Days to comply
—

Related policy hubs